Literature DB >> 23616635

Plasma microRNAs in ovarian cancer--response.

Xin Huang, Anda M Vlad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23616635      PMCID： PMC3708471          DOI： 10.1158/1078-0432.CCR-13-1022

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  6 in total

1.  The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression.

Authors:  Qun Pan; Xiaoping Luo; Tannaz Toloubeydokhti; Nasser Chegini
Journal:  Mol Hum Reprod       Date:  2007-08-31       Impact factor: 4.025

Review 2.  miRNAs and estrogen action.

Authors:  Carolyn M Klinge
Journal:  Trends Endocrinol Metab       Date:  2012-04-11       Impact factor: 12.015

3.  Maturation of microRNA is hormonally regulated by a nuclear receptor.

Authors:  Kaoru Yamagata; Sally Fujiyama; Saya Ito; Takashi Ueda; Takuya Murata; Masanori Naitou; Ken-Ichi Takeyama; Yasuhiro Minami; Bert W O'Malley; Shigeaki Kato
Journal:  Mol Cell       Date:  2009-10-23       Impact factor: 17.970

4.  Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer.

Authors:  Swati Suryawanshi; Anda M Vlad; Hui-Min Lin; Gina Mantia-Smaldone; Robin Laskey; Minjae Lee; Yan Lin; Nicole Donnellan; Marcia Klein-Patel; Ted Lee; Suketu Mansuria; Esther Elishaev; Raluca Budiu; Robert P Edwards; Xin Huang
Journal:  Clin Cancer Res       Date:  2013-01-29       Impact factor: 12.531

5.  Estradiol-regulated microRNAs control estradiol response in breast cancer cells.

Authors:  Poornima Bhat-Nakshatri; Guohua Wang; Nikail R Collins; Michael J Thomson; Tim R Geistlinger; Jason S Carroll; Myles Brown; Scott Hammond; Edward F Srour; Yunlong Liu; Harikrishna Nakshatri
Journal:  Nucleic Acids Res       Date:  2009-06-14       Impact factor: 16.971

6.  Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids.

Authors:  Qun Pan; Xiaoping Luo; Nasser Chegini
Journal:  J Cell Mol Med       Date:  2007-12-20       Impact factor: 5.310
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.